DK0573492T3 - Præparater indeholdende fluticasonpropionat og oxiconazol eller salte deraf til topisk administration - Google Patents

Præparater indeholdende fluticasonpropionat og oxiconazol eller salte deraf til topisk administration

Info

Publication number
DK0573492T3
DK0573492T3 DK92905462.5T DK92905462T DK0573492T3 DK 0573492 T3 DK0573492 T3 DK 0573492T3 DK 92905462 T DK92905462 T DK 92905462T DK 0573492 T3 DK0573492 T3 DK 0573492T3
Authority
DK
Denmark
Prior art keywords
oxiconazole
fluticasone propionate
topical administration
salts
preparations containing
Prior art date
Application number
DK92905462.5T
Other languages
Danish (da)
English (en)
Inventor
Ernest Arthur Hill
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK0573492T3 publication Critical patent/DK0573492T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK92905462.5T 1991-02-22 1992-02-21 Præparater indeholdende fluticasonpropionat og oxiconazol eller salte deraf til topisk administration DK0573492T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103764A GB9103764D0 (en) 1991-02-22 1991-02-22 Compositions

Publications (1)

Publication Number Publication Date
DK0573492T3 true DK0573492T3 (da) 1995-01-09

Family

ID=10690429

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92905462.5T DK0573492T3 (da) 1991-02-22 1992-02-21 Præparater indeholdende fluticasonpropionat og oxiconazol eller salte deraf til topisk administration

Country Status (11)

Country Link
EP (1) EP0573492B1 (de)
AT (1) ATE114244T1 (de)
AU (1) AU1277792A (de)
CA (1) CA2104677A1 (de)
DE (1) DE69200711T2 (de)
DK (1) DK0573492T3 (de)
ES (1) ES2064166T3 (de)
GB (1) GB9103764D0 (de)
GR (1) GR3015014T3 (de)
MX (1) MX9200728A (de)
WO (1) WO1992014472A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5174475A (en) * 1991-03-26 1992-12-29 Glaxo Inc. Sequential dosing of antifungal and antiinflammatory compositions
GB9823036D0 (en) 1998-10-22 1998-12-16 Glaxo Group Ltd Fluticasone lotion having improved vasoconstrictor activity
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6479058B1 (en) 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
AR032362A1 (es) * 2000-08-14 2003-11-05 Glaxo Group Ltd Formulacion topica estable de una emulsion de aceite en agua y proceso para su preparacion
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2012023077A1 (en) * 2010-08-17 2012-02-23 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - clobetasol propionate, and an antifungal agent - oxiconazole nitrate, and a process to make it

Also Published As

Publication number Publication date
ATE114244T1 (de) 1994-12-15
EP0573492A1 (de) 1993-12-15
AU1277792A (en) 1992-09-15
CA2104677A1 (en) 1992-08-23
MX9200728A (es) 1992-10-01
GR3015014T3 (en) 1995-05-31
DE69200711D1 (de) 1995-01-05
WO1992014472A1 (en) 1992-09-03
EP0573492B1 (de) 1994-11-23
DE69200711T2 (de) 1995-03-30
GB9103764D0 (en) 1991-04-10
ES2064166T3 (es) 1995-01-16

Similar Documents

Publication Publication Date Title
DK0573492T3 (da) Præparater indeholdende fluticasonpropionat og oxiconazol eller salte deraf til topisk administration
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
ITRM910922A0 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e metodo per applicarla.
DK254787A (da) Farmaceutiske praeparater til behandling af sygdomme foraarsaget af oxidativt stress og indeholdende 2-phenyl.1,2-benziso-selenazol-3(2h)-on som aktiv bestanddel
NO975192L (no) Bicykliske aromatiske forbindelser
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
DK122391A (da) Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
NO862534L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater og beslektede forbindelser.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO302170B1 (no) Enantiomerisk 1-fenyl-2-(2-pyridinyl)etylamin, farmasöytisk formulering og anvendelse derav
NO863460D0 (no) Fremgangsmaate til fremstilling av 6-fenoksymetyl-4-hydroksy-tetrahydropyran-2-on, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel, farmasoeytiske preparater og mellomprodukter.
AU3401093A (en) Therapeutic agent for threatened abortion
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
GR3029886T3 (en) Method of preparing a radioactive rhenium complex solution.
SE9000207L (sv) Laekemedel samt anvaendningen av detsamma
NO890997L (no) Applikator for hudrensemiddel, hudpleiemiddel og medisinsk salve.
MY114218A (en) The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations.
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
NO870834D0 (no) Glysero-3(2)-fosfo-l-serinderivater og salter derav, fremgangsmaater for fremstilling derav og farmasoeytiske preparater inneholdende derivatene.
SE8105500L (sv) Psykotropa lekemedel
EP0418065A3 (en) Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same
NO922635L (no) Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater
NO922229D0 (no) Peptid derivativ, fremgangsmaate til fremstilling av dissefarmasoeytiske preparater som inneholder disse og fremgangsmaate for behandling av glaucoma
DK72088D0 (da) Oximethere af 2,6-dioxabicyclo(3.3.0)octanoner og farmaceutiske praeparater til behandling af hjerte- og blodkredsloebssygdomme